Xēnix Medical specializes in innovative surgical implants aimed at enhancing spinal fusion surgery through advanced technologies. Their flagship products, such as the neoWave™ interbody system, utilize a patented 3D-printed lattice structure that significantly reduces device stiffness while maintaining strength under impaction. This unique design features edge-to-edge uniform porosity, which helps distribute dynamic loads on the vertebral endplates, creating a "Snowshoe Effect™" that allows for better bone adaptation and reduces the risk of implant subsidence. The implants are available in various sizes to accommodate different patient anatomies, ensuring a tailored approach to spinal fusion.

A key aspect of Xēnix Medical's technology is their proprietary NANOACTIV™ surface, which incorporates nanotechnology to enhance osseointegration. Engineered with nano-scale features, this surface promotes a favorable biological response, facilitating the differentiation of human mesenchymal stem cells and the production of a mineralized matrix. This innovative surface treatment not only improves fixation to adjacent bone but also increases the contact surface area, thereby enhancing the overall effectiveness of the implants. By combining advanced structural architecture with cutting-edge nanotechnology, Xēnix Medical aims to improve patient outcomes in spinal fusion procedures.

United States

Xēnix Medical is a surgical implant company focused on the development of novel science-based solutions for patients requiring spinal fusion surgery. The company, headquartered in Orlando, Florida, markets its line of spinal implant devices in the United States through a network of independent distributors.

Xēnix Medical

Company Details